Common Reference-Based Tandem Mass Tag Multiplexing for the Relative Quantification of Peptides: Design and Application to Degradome Analysis of Diphtheria Toxoid

Currently, animal tests are being used to confirm the potency and lack of toxicity of toxoid vaccines. In a consistency approach, animal tests could be replaced if production consistency (compared to known good products) can be proven in a panel of in vitro assays. By mimicking the in vivo antigen processing in a simplified in vitro approach, it may be possible to distinguish aberrant products from good products. To demonstrate this, heat-exposed diphtheria toxoid was subjected to partial digestion by cathepsin S (an endoprotease involved in antigen processing), and the peptide formation/degradation kinetics were mapped for various heated toxoids. To overcome the limitations associated with the very large number of samples, we used common reference-based tandem mass tag (TMT) labeling. Instead of using one label per condition with direct comparison between the set of labels, we compared multiple labeled samples to a common reference (a pooled sample containing an aliquot of each condition). In this method, the number of samples is not limited by the number of unique TMT labels. This TMT multiplexing strategy allows for a 15-fold reduction of analysis time while retaining the reliability advantage of TMT labeling over label-free quantification. The formation of the most important peptides could be followed over time and compared among several conditions. The changes in enzymatic degradation kinetics of diphtheria toxoid revealed several suitable candidate peptides for use in a quality control assay that can distinguish structurally aberrant diphtheria toxoid from compliant toxoids.

[1]  J. Pennings,et al.  Variability of in vivo potency tests of Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccines. , 2021, Vaccine.

[2]  W. Jiskoot,et al.  Degradomics-Based Analysis of Tetanus Toxoids as a Quality Control Assay , 2020, Vaccines.

[3]  Jeffrey R. Whiteaker,et al.  Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy , 2020, Cell.

[4]  W. Jiskoot,et al.  Formaldehyde treatment of proteins enhances proteolytic degradation by the endo-lysosomal protease cathepsin S , 2020, Scientific Reports.

[5]  Peter B. McGarvey,et al.  Proteogenomic Characterization of Endometrial Carcinoma , 2020, Cell.

[6]  W. Hennink,et al.  Identification of formaldehyde-induced modifications in diphtheria toxin. , 2020, Journal of Pharmacy and Science.

[7]  K. Kuhn,et al.  TMTpro: Design, synthesis and initial evaluation of a Proline-based isobaric 16-plex Tandem Mass Tag reagent set. , 2019, Analytical chemistry.

[8]  S. Carr,et al.  Microscaled proteogenomic methods for precision oncology , 2019, Nature Communications.

[9]  Renã A. S. Robinson,et al.  Sample Multiplexing Strategies in Quantitative Proteomics. , 2018, Analytical chemistry.

[10]  Xia Yang,et al.  Extended Multiplexing of Tandem Mass Tags (TMT) Labeling Reveals Age and High Fat Diet Specific Proteome Changes in Mouse Epididymal Adipose Tissue* , 2017, Molecular & Cellular Proteomics.

[11]  Julian E. Fuchs,et al.  Fold stability during endolysosomal acidification is a key factor for allergenicity and immunogenicity of the major birch pollen allergen , 2016, The Journal of allergy and clinical immunology.

[12]  H. Brandstetter,et al.  Protease recognition sites in Bet v 1a are cryptic, explaining its slow processing relevant to its allergenicity , 2015, Scientific Reports.

[13]  P. Briza,et al.  Correlation of sensitizing capacity and T-cell recognition within the Bet v 1 family , 2015, The Journal of allergy and clinical immunology.

[14]  J. Yates,et al.  Isobaric Labeling-Based Relative Quantification in Shotgun Proteomics , 2014, Journal of proteome research.

[15]  Julian E. Fuchs,et al.  The Impact of Nitration on the Structure and Immunogenicity of the Major Birch Pollen Allergen Bet v 1.0101 , 2014, PloS one.

[16]  V. Kulasingam,et al.  Quantitative mass spectrometry-based assay development and validation: from small molecules to proteins. , 2013, Clinical biochemistry.

[17]  J. Pennings,et al.  Quantitative proteomics reveals distinct differences in the protein content of outer membrane vesicle vaccines. , 2013, Journal of proteome research.

[18]  G. Zlabinger,et al.  A hypoallergenic variant of the major birch pollen allergen shows distinct characteristics in antigen processing and T‐cell activation , 2012, Allergy.

[19]  J. Brewer,et al.  Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro , 2012, Immunology letters.

[20]  P. Briza,et al.  Pru p 3, the nonspecific lipid transfer protein from peach, dominates the immune response to its homolog in hazelnut , 2011, Allergy.

[21]  P. Briza,et al.  Assessing Protein Immunogenicity with a Dendritic Cell Line-Derived Endolysosomal Degradome , 2011, PloS one.

[22]  R. Cole,et al.  A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes , 2010, Nature Medicine.

[23]  R. Cole,et al.  A novel Minimalist Cell-Free MHC Class II Antigen Processing System Identifies Immunodominant Epitopes , 2010, Nature medicine.

[24]  I. Mellman,et al.  Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis , 2006, The Journal of experimental medicine.

[25]  Henry C. Chang,et al.  Differential Lysosomal Proteolysis in Antigen-Presenting Cells Determines Antigen Fate , 2005, Science.

[26]  W. Hennink,et al.  Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines. , 2003, Vaccine.

[27]  Andrew H. Thompson,et al.  Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. , 2003, Analytical chemistry.

[28]  J Quackenbush,et al.  Use of RNA and genomic DNA references for inferred comparisons in DNA microarray analyses. , 2002, BioTechniques.

[29]  H. Meiring,et al.  Nanoscale LC–MS(n): technical design and applications to peptide and protein analysis , 2002 .

[30]  E. London,et al.  Comparison of the conformation, hydrophobicity, and model membrane interactions of diphtheria toxin to those of formaldehyde-treated toxin (diphtheria toxoid): formaldehyde stabilization of the native conformation inhibits changes that allow membrane insertion. , 1996, Biochemistry.

[31]  R. Collier,et al.  The amino acid sequence of fragment A, an enzymically active fragment of diphtheria toxin. III. The chymotryptic peptides, the peptides derived by cleavage at tryptophan residues, and the complete sequence of the protein. , 1979, The Journal of biological chemistry.

[32]  Mandy Berg,et al.  Handbook Of Proteolytic Enzymes , 2016 .

[33]  G. Siuzdak Peptide and Protein Analysis , 1996 .